-
Vanderbilt CTTC Honors Five Pioneering Faculty as newly-inducted Master Innovators
The 2024 Master Innovators are chosen based on their achievements across multiple categories involving innovation and entrepreneurship, including inventions made, patents issued, technologies licensed, companies launched, products on the market, and several other factors.Dec 05, 2024
-
Vanderbilt-discovered cancer killing compound is now available through Boehringer Ingelheim open science portal opnMe
Researchers in the lab of Stephen Fesik, Orrin H. Ingram II Chair in Cancer Research, have added BI-0474 as the second molecule co-discovered by Vanderbilt to the open science portal opnMe.com, an initiative being driven by biopharmaceutical company Boehringer Ingelheim.Jun 03, 2024